Last reviewed · How we verify
NCT05858697
Weight Development in Children With Obesity After Declining Treatment
trial testing Declining participation in the Aarhus intervention in Obesity, Child in 1,273 participants. Completed in 25 April 2023.
30 June 2020
Quick facts
| Lead sponsor | University of Aarhus |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,273 |
| Start date | 1 January 2010 |
| Primary completion | 30 June 2020 |
| Estimated completion | 25 April 2023 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- Declining participation in the Aarhus intervention
- Participation in the Aarhus intervention
Conditions studied
- Obesity, Child — all drugs for Obesity, Child →
Sponsor
University of Aarhus
Who can join
Adults 5 to 7, any sex, with Obesity, Child. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Childhood obesity is a major health concern and lifestyle intervention is recommended as the cornerstone in the weight loss treatment. However, only limited knowledge exists in relation to characterization and follow-up of children who decline participation in a lifestyle intervention. The aim of this study is to investigate the long-term development in BMI z-score for children with obesity who decline to participate in a lifestyle intervention. This study identified approximately 170 children with obesity who declined treatment in a community-based lifestyle intervention. The development in BMI z-score for these children will be compared to children enrolled in the lifestyle intervention (i.e. treatment) and children who were never invited. Data from different sources will be used to answer the research question (intervention registries, health check-ups at school and Danish registries).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Does deciding not to participate in a lifestyle intervention for children with obesity affect the long-term weight change?
Jørgensen RM, Østergaard JN, Fogh M, Taylor RW, et al · · 2025 · cited 3× · PMID 39978404 · DOI 10.1002/oby.24231
Verify or expand the search:
- PubMed search for NCT05858697
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Obesity, Child
Currently open trials in the same condition.
- NCT07404839 — Scaling up Building Healthy Families · NA · active not recruiting
- NCT05667753 — Large Scale Implementation of MINISTOP 3.0 · NA · active not recruiting
Other University of Aarhus trials
Trials by the same sponsor.
- NCT07209540 — European LUpuS Inception-Cohort Developing initiATivE · not yet recruiting
- NCT07317401 — Investigating the Effects of Intermittent Hypoxia-Hyperoxia Treatment (IHHT) in People With Post-Viral Myalgic Encephalo · NA · not yet recruiting
- NCT07531966 — Vascular Complications After Kidney Transplantation · recruiting
- NCT07528339 — Prospective RegIstry for Oncologic Reirradiation (PRIOR-DK) · not yet recruiting
- NCT07451028 — Effect of an Oral Neuromuscular Training Device on Dysphagia · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05858697 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Aarhus
- Last refreshed: 15 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05858697.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing